Artivion (AORT) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free AORT Stock Alerts $23.73 +0.29 (+1.24%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 1:30 AM | americanbankingnews.comArtivion (NYSE:AORT) versus Pulse Biosciences (NASDAQ:PLSE) Critical SurveyMay 11, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) SVP Jean F. Holloway Sells 979 SharesMay 10, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) SVP Sells $23,290.41 in StockArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Jean F. Holloway sold 979 shares of the firm's stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $23.79, for a total transaction of $23,290.41. Following the completion of the transaction, the senior vice president now directly owns 168,732 shares of the company's stock, valued at approximately $4,014,134.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.May 8, 2024 | finance.yahoo.comShareholders Will Probably Hold Off On Increasing Artivion, Inc.'s (NYSE:AORT) CEO Compensation For The Time BeingMay 8, 2024 | americanbankingnews.comArtivion (NYSE:AORT) Given New $30.00 Price Target at Needham & Company LLCMay 8, 2024 | americanbankingnews.comArtivion (NYSE:AORT) Given New $25.00 Price Target at Stifel NicolausMay 8, 2024 | americanbankingnews.comArtivion (NYSE:AORT) Sets New 1-Year High on Better-Than-Expected EarningsMay 7, 2024 | markets.businessinsider.comArtivion: Strong Q1 Performance and Raised Guidance Validate Buy RatingMay 7, 2024 | markets.businessinsider.comBreaking Down Artivion: 4 Analysts Share Their ViewsMay 7, 2024 | msn.comArtivion, Inc. (NYSE:AORT) Q1 2024 Earnings Call TranscriptMay 7, 2024 | marketbeat.comArtivion (NYSE:AORT) Reaches New 1-Year High After Better-Than-Expected EarningsArtivion (NYSE:AORT) Hits New 1-Year High Following Earnings BeatMay 7, 2024 | marketbeat.comArtivion (NYSE:AORT) Price Target Raised to $25.00Stifel Nicolaus raised their target price on Artivion from $22.00 to $25.00 and gave the stock a "buy" rating in a research report on Tuesday.May 7, 2024 | marketbeat.comArtivion (NYSE:AORT) Announces Earnings ResultsArtivion (NYSE:AORT - Get Free Report) released its quarterly earnings results on Monday. The company reported $0.06 EPS for the quarter, beating analysts' consensus estimates of $0.02 by $0.04. Artivion had a negative net margin of 8.67% and a positive return on equity of 3.02%. During the same period last year, the firm earned $0.02 EPS.May 7, 2024 | finance.yahoo.comArtivion Inc (AORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and Strategic ...May 7, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Axonics Modulation Technologies (AXNX) and Artivion (AORT)May 7, 2024 | msn.comAORT Stock Earnings: Artivion Beats EPS, Beats Revenue for Q1 2024May 6, 2024 | uk.finance.yahoo.comArtivion Inc (AORT) Surpasses Analyst Revenue Forecasts with Strong Q1 2024 PerformanceMay 6, 2024 | prnewswire.comArtivion Reports First Quarter 2024 Financial ResultsApril 30, 2024 | msn.comAtriCure Q1 2024 Earnings PreviewApril 30, 2024 | finance.yahoo.comArtivion presents double win at AATS for aortic devicesApril 29, 2024 | prnewswire.comArtivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual MeetingApril 29, 2024 | marketbeat.comArtivion (AORT) to Release Quarterly Earnings on MondayArtivion (NYSE:AORT) will be releasing earnings after the market closes on Monday, May 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587495)April 22, 2024 | prnewswire.comArtivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial ResultsApril 19, 2024 | finance.yahoo.comArtivion's (NYSE:AORT) investors will be pleased with their notable 43% return over the last yearApril 10, 2024 | marketbeat.comVanguard Group Inc. Sells 96,114 Shares of Artivion, Inc. (NYSE:AORT)Vanguard Group Inc. lessened its position in Artivion, Inc. (NYSE:AORT - Free Report) by 3.5% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,646,643 shares of the company's stock after selling 96,114 shareApril 9, 2024 | marketbeat.comArtivion (NYSE:AORT) Hits New 1-Year High at $21.90Artivion (NYSE:AORT) Hits New 12-Month High at $21.90April 8, 2024 | marketbeat.comArtivion (NYSE:AORT) Earns Buy Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $25.00 price target on shares of Artivion in a report on Monday.April 1, 2024 | finance.yahoo.comArtivion to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceMarch 27, 2024 | marketbeat.comArtivion (NYSE:AORT) Sets New 1-Year High at $21.44Artivion (NYSE:AORT) Reaches New 52-Week High at $21.44March 22, 2024 | insidertrades.comMarshall S. Stanton Sells 2,183 Shares of Artivion, Inc. (NYSE:AORT) StockMarch 21, 2024 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) SVP Sells 2,183 Shares of StockArtivion, Inc. (NYSE:AORT - Get Free Report) SVP Marshall S. Stanton sold 2,183 shares of the company's stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $20.39, for a total value of $44,511.37. Following the completion of the transaction, the senior vice president now directly owns 83,296 shares in the company, valued at $1,698,405.44. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.March 21, 2024 | marketbeat.comWellington Management Group LLP Has $38.01 Million Holdings in Artivion, Inc. (NYSE:AORT)Wellington Management Group LLP cut its stake in Artivion, Inc. (NYSE:AORT - Free Report) by 2.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,507,056 shares of the company's stock after selMarch 20, 2024 | marketbeat.comArtivion (NYSE:AORT) Sets New 1-Year High at $20.61Artivion (NYSE:AORT) Hits New 12-Month High at $20.61March 20, 2024 | investing.comArtivion's VP regulatory sells shares worth over $29kMarch 19, 2024 | marketbeat.comExchange Traded Concepts LLC Purchases New Position in Artivion, Inc. (NYSE:AORT)Exchange Traded Concepts LLC acquired a new position in Artivion, Inc. (NYSE:AORT - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 51,223 shares of the company's stock, valued at approximately $916,0March 19, 2024 | insidertrades.comArtivion, Inc. (NYSE:AORT) VP Sells $29,240.00 in StockMarch 18, 2024 | marketbeat.comInsider Selling: Artivion, Inc. (NYSE:AORT) VP Sells 1,462 Shares of StockArtivion, Inc. (NYSE:AORT - Get Free Report) VP Andrew M. Green sold 1,462 shares of the stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $20.00, for a total transaction of $29,240.00. Following the sale, the vice president now owns 41,121 shares in the company, valued at approximately $822,420. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 17, 2024 | uk.investing.comArtivion VP regulatory sells shares worth $79,880March 17, 2024 | insidertrades.comInsider Selling: Artivion, Inc. (NYSE:AORT) CAO Sells 1,152 Shares of StockMarch 16, 2024 | uk.investing.comArtivion executive sells shares worth nearly $100kMarch 16, 2024 | insidertrades.comMatthew A. Getz Sells 5,000 Shares of Artivion, Inc. (NYSE:AORT) StockMarch 14, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) VP Sells $99,700.00 in StockArtivion, Inc. (NYSE:AORT - Get Free Report) VP Matthew A. Getz sold 5,000 shares of the company's stock in a transaction on Tuesday, March 12th. The shares were sold at an average price of $19.94, for a total transaction of $99,700.00. Following the completion of the transaction, the vice president now owns 43,536 shares of the company's stock, valued at approximately $868,107.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.March 9, 2024 | marketbeat.comGSA Capital Partners LLP Purchases 53,773 Shares of Artivion, Inc. (NYSE:AORT)GSA Capital Partners LLP lifted its position in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 187.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 82,449 shares of the company's stock after purchaMarch 6, 2024 | prnewswire.comArtivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceMarch 1, 2024 | marketbeat.com37,350 Shares in Artivion, Inc. (NYSE:AORT) Bought by Algert Global LLCAlgert Global LLC purchased a new stake in shares of Artivion, Inc. (NYSE:AORT - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 37,350 shares of the company's stock, valued at approximately $566,000. Algert GlobFebruary 21, 2024 | finance.yahoo.comWall Street Analysts Think Artivion (AORT) Could Surge 30.7%: Read This Before Placing a BetFebruary 16, 2024 | marketbeat.comArtivion, Inc. (NYSE:AORT) Sees Significant Decline in Short InterestArtivion, Inc. (NYSE:AORT - Get Free Report) was the target of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 2,750,000 shares, a decrease of 5.2% from the January 15th total of 2,900,000 shares. Currently, 7.1% of the shares of the company are short sold. Based on an average trading volume of 226,100 shares, the short-interest ratio is currently 12.2 days.February 16, 2024 | finance.yahoo.comArtivion, Inc. (NYSE:AORT) Q4 2023 Earnings Call TranscriptFebruary 16, 2024 | marketbeat.comStifel Nicolaus Increases Artivion (NYSE:AORT) Price Target to $22.00Stifel Nicolaus increased their target price on Artivion from $20.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday.February 16, 2024 | marketbeat.comArtivion (NYSE:AORT) Reaches New 1-Year High After Analyst UpgradeArtivion (NYSE:AORT) Hits New 1-Year High Following Analyst Upgrade Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address This unknown company solves the biggest issue with AI (Ad)Nvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in. Discover why this company AORT Media Mentions By Week AORT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AORT News Sentiment▼0.670.55▲Average Medical News Sentiment AORT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AORT Articles This Week▼52▲AORT Articles Average Week Get Artivion News Delivered to You Automatically Sign up to receive the latest news and ratings for AORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AtriCure News Today MiMedx Group News Today Paragon 28 News Today OrthoPediatrics News Today Silk Road Medical News Today Atrion News Today Treace Medical Concepts News Today SI-BONE News Today Embecta News Today Iradimed News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AORT) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersHow to Play the AI and Crypto Markets in One SwingWeiss RatingsAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artivion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
